Clinical significance of serum anti-granulocyte–macrophage colony-stimulating factor autoantibodies in patients with sarcoidosis and hypersensitivity pneumonitis

BACKGROUND: Anti-granulocyte–macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of serum GMAb in granulomatous lung diseases...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Orphanet J Rare Dis
Hauptverfasser: Katayama, Kanako, Hirose, Masaki, Arai, Toru, Hatsuda, Kazuyoshi, Tachibana, Kazunobu, Sugawara, Reiko, Sugimoto, Chikatoshi, Kasai, Takahiko, Akira, Masanori, Inoue, Yoshikazu
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2020
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7525969/
https://ncbi.nlm.nih.gov/pubmed/32993757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-01546-x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge